Pharmacy (PHRM)

This biochemistry course describes the chemistry and metabolism of carbohydrates, lipids, and proteins. It also addresses blood clotting and selected topics of the production and degradation of blood cells.

This course will provide an understanding of commonly used research methods and statistical tests, the skills needed to manage data sets and evaluate statistical results, and the knowledge necessary to apply the concepts of statistical versus clinical significance to practice. The course is a practical approach to using statistical tests in a research framework. The focus of the course is on enabling students to become consumers of the research literature rather than biostatisticians.

This course focuses on disease prevention and wellness promotion through heath risk assessment, lifestyle modification, and the use of other nonpharmacologic therapies. It evaluates the role of nonprescription drug therapies and dietary supplements in preventive healthcare and patient self-care.

Medicinal chemistry addresses the physicochemical properties of drug molecules, the chemical basis of pharmacology and therapeutics, fundamental pharmacophores for drugs used to treat disease, structure-activity-relationships (SAR) pertaining to drug-target interactions and chemical pathways of drug metabolism. The main objective of the course is to understand how the chemical structures of drugs determine their biological properties, including absorption, distribution to sites of action, interactions with pharmacological targets, metabolic inactivation, forms and routes of elimination, and therapeutic potential. The course is designed to include basic chemical concepts that govern drug action, general principles of medicinal chemistry, and chemical characteristics of selected drug classes. Students will also gain an understanding of how these principles can be generally applied to making drug therapy decisions. Learning activities in the course consist primarily of lectures, recitations, and problem-solving exercises.

Provides an understanding of the basic principles and mechanisms of disease, including but not limited to: inflammation and repair; degeneration; hemodynamic disturbances; and developmental defects related to disorders affecting the hematologic, endocrine, cardiovascular, renal, genitourinary, and respiratory systems. This level of understanding will be applied through patient cases to address disease states amenable to pharmacist intervention. In addition, medical terminology will be learned and applied to the course content.

Provide an understanding of the basic principles and mechanisms of diseases affecting the neurologic, psychiatric, gastrointestinal, musculoskeletal, immunologic, integumentary systems, and hematological and solid organ oncology, through discussion of but not limited to inflammation and repair; degeneration; hemodynamic disturbances; developmental defects; and neoplasia. This level of understanding will be applied through patient cases to address disease states amenable to pharmacist intervention. In addition, medical terminology will be learned and applied to the course content.

Provides an overview of the pharmacy profession and the history of pharmacy as well as discussion surrounding what it means to be a professional (including but not limited to issues of ethics, cultural competency and emotional intelligence). Pharmacy law, as it relates to the IPPE courses, will be introduced to the student. Student participation in the Jefferson Health Mentors Program will be encompassed within this course series.

Provides an overview of the role of the pharmacy profession relative to different areas of practice and in the role as advocate for healthcare. Continued reflection regarding what it means to be a professional will occur. Other social and behavioral aspects of pharmacy will be addressed through class discussions and the Jefferson Health Mentors program and will include patient and other healthcare provider perceptions of pharmacists’ capabilities, role of the pharmacist related to patient care, and role of the pharmacist related to interaction with other healthcare providers.

Provides an introduction to the U.S. health care delivery system; addresses the social, political, and economic context of U.S. health care, the distribution of medical care and pharmaceutical products and services, as well as the role of public and private insurers, pharmaceutical industry, and managed care organizations on health care delivery in the U.S.

This molecular and cellular biology course contains instruction on nucleotide metabolism, the classic concept of DNA to RNA to protein, the structure and behavior of cells, and the major modes of inheritance. This course will prepare students for topics that are covered in the Pathophysiology and Clinical Diagnosis/Pharmacotherapy courses.

This course will introduce pharmacy students to the calculations commonly used in pharmacy practice. The knowledge and skills learned in this course will prepare students to apply calculation problem solving skills to clinical practice. Topics discussed will focus on the pharmaceutical and clinical calculations that are critical to the safe and effective delivery of medications to the patient.

Introductory Pharmacy Practice Experiences (IPPE) are structured and sequenced rotations to intentionally develop in student pharmacists a clear understanding of what constitutes exemplary pharmacy practice in the U.S. prior to beginning the APPE curriculum. These introductory rotations will involve student pharmacists in common contemporary U.S. practice models, including interprofessional practice involving shared patient care decision making, professional ethics and expected behaviors, and patient care activities. Utilizing ACPE Standards 2025, each IPPE will include the educational outcomes (EO) and the Entrustable Professional Activities (EPA). This course is conducted at service sites in and around the region.

Introductory Pharmacy Practice Experiences (IPPE) are structured and sequenced rotations to intentionally develop in student pharmacists a clear understanding of what constitutes exemplary pharmacy practice in the U.S. prior to beginning the APPE curriculum. These introductory rotations will involve student pharmacists in common contemporary U.S. practice models, including interprofessional practice involving shared patient care decision making, professional ethics and expected behaviors, and patient care activities. Utilizing ACPE Standards 2025, each IPPE will include the educational outcomes (EO) and the Entrustable Professional Activities (EPA). This course is conducted in the community pharmacy setting.

Lecture course that examines the basic principles and mechanisms of the immune system in the physiological condition and how it relates to diseases, including immune cellular and systematic mechanisms in infections, hypersensitivity reactions, autoimmunity, immunodeficiencies, tumors, and transplantation.

Physical assessment and clinical skills provides the student with knowledge of the skills necessary for obtaining a comprehensive patient history and problem identification. Students will learn to design patient-centered, culturally relevant pharmacy care plans and appreciate the role of these plans in patient care. Students will learn basic assessment techniques and the skills necessary for triage and referral. This course will also introduce the role of home diagnostic and monitoring devices in the diagnosis, staging, and monitoring of various disease states.

This course emphasizes the skills needed to develop drug information for dissemination to health care providers. Emphasizes the types of drug information available, what sources are appropriate to use in a variety of situations and the strengths and weaknesses of different sources. Provides the knowledge and skills necessary to evaluate clinical trials that validate treatment usefulness, to apply evidence-based decision making to patient care and develop guidelines. The course provides an overview of how medical information skills are applicable, and necessary, in various settings. Examples include medical information in the pharmaceutical Industry, development of evidence-based guidelines, application of informatics to facilitate guideline adherence, key points to secure when responding to a specific question type such as drug use in pregnancy, and newer information sources such as mobile apps and social media. Pre-Req: PHRM511

Introductory Pharmacy Practice Experiences (IPPE) are structured and sequenced rotations to intentionally develop in student pharmacists a clear understanding of what constitutes exemplary pharmacy practice in the U.S. prior to beginning the APPE curriculum. These introductory rotations will involve student pharmacists in common contemporary U.S. practice models, including interprofessional practice involving shared patient care decision making, professional ethics and expected behaviors, and patient care activities. Utilizing ACPE Standards 2025, each IPPE will include the educational outcomes (EO) and the Entrustable Professional Activities (EPA). This course is conducted in the hospital pharmacy setting.

This course will provide students with an understanding of the basic safety principles employed in the medication-use process. These principles include the following: understanding systems thinking; identifying the types and causes of medication errors; developing strategies for improving the medication-use process; and defining the role of medication safety resources and reporting systems. Co-Req: PHRM 527 and PHRM 521

Pharmaceutics deals with the formulation, preparation, preservation, and dispensing of medications and related therapeutic devices. A successful dosage form or drug delivery system must ensure the effective, reliable, and safe delivery of the drug to its site of action in the body. The course will explore the many physical, chemical, engineering, organoleptic, and esthetic principles involved in dosage form design and preparation. From tablets and capsules to syrups and injectable, the student will gain an in-depth appreciation of the role of dosage form characteristics relative to the route of administration in drug therapy decisions. Learning activities in the course consist of lectures, problem-solving exercises, and quizzes with feedback review. Co-Req: PHRM 521

This course will introduce the student to dosage forms utilized by today’s compounding pharmacists and will provide students with an understanding of the prescription and pharmaceutical calculations, including the metric and common systems of measurement, calculation of doses, and various methods of expressing the strength of pharmaceuticals. Upon completion, students should be able to perform correctly the calculations required to prepare a medication order properly. A range of dosage forms will be discussed and prepared, with an emphasis on formulation, preparation and presentation of solid, semi- solid and liquid dosage forms with a specific focus on blends and mixtures (capsules, suppositories, troches, solutions and dispersions; emulsions and suspensions) for oral, rectal, vaginal, topical and transdermal routes of delivery. Co-Req: PHRM 521 and PHRM 530

This course will enable students to apply management principles (planning, organizing, directing and controlling resources) to various pharmacy practice settings. It provides an introduction to marketing principles, basic accounting principles, project management issues, managing and improving the medication-use process, and topics related to healthcare improvement mechanisms at the micro- and macro-system levels. Through class discussions and group project work, students have the opportunity to research innovative concepts and develop entrepreneurial skill as they create and build justification for the business case for their assigned pharmacy programs. Students are encouraged to investigate current landscape of existing programs and to develop new and innovative approaches to solving current practice setting challenges.

This is the 3rd course in the 4-course Pharmacy Practice course sequence. This semester we include continued reflection about what it means to be a professional with additional exercises and discussions on cultural competency and emotional intelligence.   We will continue discussions about pharmacy law - especially how state laws define the scope of practice of pharmacists and regulations for pharmacy operations. Other social and behavioral aspects of pharmacy are addressed through class discussion and the Jefferson Health Mentors Program.

Biopharmaceutics is the science that examines the interrelationships between physicochemical properties of a drug, the dosage form, specific formulation, and route of administration with the rate and extent of drug absorption into the systemic circulation, distribution, metabolism, and elimination from the body. Pharmacokinetics is the science of the kinetics (rates) of drug absorption, distribution, metabolism, and elimination in an in-vivo system. Dissecting and modeling the interplay among these factors is the purview of biopharmaceutics and pharmacokinetics. The knowledge and algorithms derived from such exercises are routinely applied to facilitate dosage form design, to predict medication dosing regimens, and to optimize treatment protocols for individual patients based on their specific profiles. This course is designed to include key mathematical, physicochemical, and biological principles that govern the fate of a dosage form or its active ingredient as it traverses the many varied barriers between the site of administration, the site of action, and the site and mode of elimination. Learning activities in the course consist primarily of lectures, discussions, and problem-solving exercises or assignments.

Introductory Pharmacy Practice Experiences (IPPE) are structured and sequenced rotations to intentionally develop in student pharmacists a clear understanding of what constitutes exemplary pharmacy practice in the U.S. prior to beginning the APPE curriculum. These introductory rotations will involve student pharmacists in common contemporary U.S. practice models, including interprofessional practice involving shared patient care decision making, professional ethics and expected behaviors, and patient care activities. Utilizing ACPE Standards 2025, each IPPE will include the educational outcomes (EO) and the Entrustable Professional Activities (EPA). This course is conducted in the ambulatory care pharmacy setting.

The fourth course in this course series, Pharmacy Practice IV includes continued focus on professional development with further discussion and exercises surrounding pharmacy services, bioethics, patient safety, cultural competency and humility, and emotional intelligence. Presentations by individuals practicing in a variety of pharmacy environments continue. Class discussions will address other social and behavioral aspects of pharmacy.

Pharmacology III focuses on drugs effective for the chemotherapy, biological and hormonal therapies for cancer, drugs applicable for the treatment of neurological and psychiatric disorders, and abusable drugs that modulate normal ranges of behavior. The neuropharmacology section begins with a review of the structures and mediators that play key roles in various brain functions, identifies neurochemical opportunities for pharmacologically targeting associated brain dysfunctions, and describes the properties of various classes of agents in current use. The cancer pharmacology section will begin with common classification of anti-cancer agents, followed by introduction of each class of anti-cancer agents. Students will gain an understanding of the mechanisms of therapeutic and adverse actions of drugs. Pre-Req: PHRM 510, PHRM 513 and PHRM 549

This course will expand the student’s pharmacotherapeutic foundation of knowledge by incorporating active learning experiences and reinforcing skills related to course content covered through Spring of the P2 year.  Students will also learn and perform immunization administration and are expected to earn an APhA Pharmacy-Based Immunization Delivery Program certificate. In addition, it will further increase the student’s level of experience relative to communication skills and introduce them to new pharmacy skills where applicable. Co-Req: PHRM 554 and PHRM 555 Pre-Req: PHRM 521, PHRM 527 and PHRM 549

This is the fourth course in the series that builds upon knowledge and skills that have been acquired in Medicinal Chemistry, Pharmacology I, Pathophysiology I and II, and other basic and clinical science courses. This course will allow the learner to develop and apply critical thinking skills toward the management of patients with infectious diseases. The course is designed to be active learning via case-based discussions. Students will be provided patient cases to work up covering infectious diseases. Students will utilize the instructional resources (e.g. textbook, journal articles, guidelines, etc.) to work through the cases prior to class and come prepared to actively engage in the in-class discussion. At the conclusion of this course, the learner will have a firm knowledge base in the diagnosis and clinical management of patients with common infectious diseases. Pre-Req: PHRM 510, PHRM 513, PHRM 514, PHRM 515, PHRM 520, PHRM525, PHRM 549 and PHRM 556

This course will expand the student’s pharmacotherapeutic foundation by incorporating active learning experiences and reinforcing skills related to clinical and physical assessment.  In addition, it will further increase the student’s level of experience relative to written and verbal communication skills and introduce them to new pharmacy skills where applicable.  Students will also learn aseptic technique and perform sterile compounding.  Co-Req: PHRM 557 and PHRM 544 Pre-Req: PHRM521, PHRM 527, PHRM 554 and PHRM 555

This is the fifth course in the Clinical Diagnosis / Pharmacotherapy series. This course will allow the learner to develop and apply critical thinking skills toward the management of patients with psychiatric and neurological disorders (along with a few others). The course is designed to have an active learning focus via case-based discussions. Students will be provided patient cases to work-up covering psychiatric and neurological disorders. Students will utilize assigned instructional resources to work through assigned cases prior to class and come prepared to actively engage during the class discussions. At the conclusion of this course, the learner will have a firm knowledge base in the diagnosis and clinical management of patients with common psychiatric and neurological disorders. Co-Req: PHRM 548 and PHRM 552 Pre-Req: PHRM 510, PHRM, PHRM 514, PHRM 515, PHRM 520, PHRM 521, PHRM525 and PHRM 539

This is the sixth course in the Clinical Diagnosis/Pharmacotherapy series that builds upon knowledge and skills acquired in Medicinal Chemistry, Pharmacology III, Pathophysiology I and II, and other basic and clinical science courses. This course will allow the learner to develop and apply critical thinking skills toward the management of cancer other miscellaneous conditions. The course is designed to be active learning via case-based discussions. Students will be provided patient cases to work up covering oncology diseases and other miscellaneous conditions. Students will utilize the instructional resources (e.g. textbook, journal articles, guidelines, etc.) to work through the cases prior to class and come prepared to actively engage in class discussions. At the conclusion of this course, the learner will have a firm knowledge base in the diagnosis, clinical treatment and supportive care management of patients with cancer and other miscellaneous conditions. Co-Req: PHRM 548 and PHRM 552 Pre-Req: PHRM 510, PHRM, PHRM 514, PHRM 515, PHRM 520, PHRM 521, PHRM525 and PHRM 539

This course will expand and reinforce the student’s pharmacotherapeutic foundation of knowledge by incorporating active learning experiences and skills related to clinical and physical assessment.  In addition, it will further increase the student’s level of experience relative to verbal and written communication skills and introduce them to new pharmacy skills where applicable.  Students are also expected to complete Comprehensive Medication Management Collaborative training. Co-Req: PHRM 546 and PHRM 547 Pre-Req: PHRM 521

Pharmacology I provides an understanding of drug action in the framework of human physiology, biochemistry, and pathophysiology. The main objectives of the course are i) to provide an introduction to pharmacodynamic parameters of drug action, drug-receptor interaction, drug toxicity, adverse drug reactions and pharmacogenetics; and ii) to understand the pharmacology related to particular physiological or biochemical systems including the endocrine system, immune system, respiratory system, gastrointestinal tract in addition to anti-infective drugs. The course is designed to include the pharmacology aspect of each biological system, presentation of drugs and drug classes that activate or inhibit the system by interacting with specific molecular and cellular targets, and discussion of the pathophysiological targets of each system-associated disorder. Students will gain an understanding of the therapeutic and adverse actions of drugs in the framework of the drug’s mechanism of action. Learning activities in the course consist primarily of lectures, technology-assisted discussions, Nearpod sessions, problem-solving exercises, in-class quizzes and team-based learning (TBL). Pre-Req: PHRM510 and PHRM513

Students will evaluate the influence of current social, political, and cultural issues on the United States healthcare system and on patient-centered care. Topics of discussion vary and include interprofessional teamwork, technology in healthcare, innovations in practice, and the impact of social drivers of health on health and healthcare delivery, among others. Students address these issues, incorporating principles of professional behavior and ethical issues in the delivery of patient-centered care.

Covers the science of pharmacoeconomics including design, methods, and analysis; discusses the context and uses of pharmacoeconomic analysis in U.S. healthcare decision making from various perspectives; explains global application of pharmacoeconomics to inform pharmaceutical reimbursement policies and decisions.

This course serves as the capstone course to the P1 through P3 curriculum. Students utilize the knowledge and skills obtained throughout the curriculum to date to practice a comprehensive approach (clinical, social, administrative) to evaluating integrated clinical problems and cases and defending therapeutic recommendations, across practice settings with frequent instructor feedback. Case evaluation is guided by the Pharmacists’ Patient Care Process and prepares the student to solve problems in the clinical learning environment. Co-Req: PHRM 546 and PHRM 547 Pre-Req: PHRM 554, PHRM 555, PHRM 557 and PHRM 544

The student will assess, develop, and present an individual presentation focusing on a specific pharmacotherapeutic topic. The course will emphasize critical thinking and effective verbal communication skills and allow students to apply biostatistics and literature evaluation skills. Pre-Req: PHRM 511 and PHRM 527

This is the first course in the series that builds upon knowledge and skills that have been acquired in Medicinal Chemistry, Pharmacology I, Pathophysiology I and II, Physical Assessment and Clinical Skills, and other basic and clinical science courses. This course will introduce basic therapeutic principles and allow the learner to develop and apply critical thinking skills toward the management of patients with endocrine disorders. The course is designed to have an active learning focus via case-based discussions. Students will be provided patient cases to work up covering therapeutic principles, and endocrine disorders. Students will utilize the instructional resources (e.g. textbook, journal articles, guidelines, etc.) and come prepared to actively engage in the in-class discussion. At the conclusion of this course, the learner will have a firm knowledge base in basic therapeutic principles, and diagnosis and clinical management of patients with common endocrine disorders. Co-Req: PHRM 542 Pre-Req: PHRM 510, PHRM 513, PHRM 514, PHRM 515, PHRM 520, PHRM 521, PHRM 525 and PHRM 549

This is the second course in the series that builds upon knowledge and skills that have been acquired in Medicinal Chemistry, Pharmacology I and II, Pathophysiology I and II, and other basic and clinical science courses. This course will allow the learner to develop and apply critical thinking skills toward the management of patients with common renal, gastrointestinal and immunologic disorders. The course is designed to have an active learning focus via case- based discussions and team-based learning exercises. Students will be provided patient cases to work up and will utilize the instructional resources (e.g., textbook, journal articles, guidelines, etc.) to work through the cases prior to class and come prepared to actively engage in the in-class discussion. At the conclusion of this course, the learner will have a firm knowledge base in the diagnosis and clinical management of patients with renal, gastrointestinal and immunologic disorders. Co-Req: PHRM 542 Pre-Req: PHRM 510, PHRM 513, PHRM 514, PHRM 515, PHRM 520, PHRM525 and PHRM 549

Pharmacology II will be the second course in this series; it will provide an understanding of drug action in the context of human physiology, biochemistry, and pathophysiology. Pharmacology II will encompass the pharmacology of bacterial and mycobacterial infections, autonomic pharmacology, and cardiovascular pharmacology. Pharmacology of bacterial infections will include cell wall synthesis inhibitors, DNA replication inhibitors, and protein synthesis inhibitors. Autonomic pharmacology will include an overview of the autonomic nervous system (sympathetic and parasympathetic), and adrenergic and cholinergic pharmacology. Cardiovascular pharmacology will include an overview of cardiac, vascular, and renal physiology, as they relate to the control of cardiovascular function, and the mechanisms of action of drugs used to treat cardiovascular disorders. Learning activities in the course consist primarily of lectures, technology-assisted discussions, Nearpod sessions, problem-solving exercises, in-class quizzes and team-based learning (TBL). Pre-Req: PHRM 513 and PHRM 549

This is the third course in the series that builds upon knowledge and skills that have been acquired in Medicinal Chemistry, Pharmacology I and II, Pathophysiology I and II, Physical Assessment and Clinical Skills and other basic and clinical science courses. This course will allow the learner to develop and apply critical thinking skills toward the management of patients with cardiovascular and pulmonary disorders. The course is designed to have an active learning focus via case-based discussions. Students will be provided patient cases to work-up covering cardiovascular and pulmonary disorders. Students will utilize the instructional resources (e.g. textbook, journal articles, guidelines, etc.) to work through the cases prior to class and come prepared to actively engage during the in-class discussion. At the conclusion of this course, the learner will have a firm knowledge base in the diagnosis and clinical management of patients with common cardiovascular and pulmonary disorders. Pre-Req: PHRM 510, PHRM 513, PHRM 514, PHRM 515, PHRM 520, PHRM525, PHRM 549 and PHRM 556

Introductory Pharmacy Practice Experiences (IPPE) are structured and sequenced rotations to intentionally develop in student pharmacists a clear understanding of what constitutes exemplary pharmacy practice in the U.S. prior to beginning the APPE curriculum. These introductory rotations will involve student pharmacists in common contemporary U.S. practice models, including interprofessional practice involving shared patient care decision making, professional ethics and expected behaviors, and patient care activities. Utilizing ACPE Standards 2025, each IPPE will include the educational outcomes (EO) and the Entrustable Professional Activities (EPA). This course is conducted in a direct patient care pharmacy setting

This course will introduce students to the application of foundational knowledge and essential skills for pharmacy practice and patient care through active learning experiences related to course content delivered simultaneously in other Fall P1 courses. This includes effective communication, verbally and in writing, to both patients and health care practitioners, as well as the use of the pharmacists' patient care process (PPCP) for self-care conditions. Co-Req: PHRM 512

This course is designed to acquaint the pharmacy student with current pharmacy professionals who are considered to be leaders within the profession. The student will also become familiar with characteristics common amongst leaders.

This course is designed to expand the student’s current knowledge base regarding the pediatric population and to introduce the core concepts involved in the care of special populations. The course is provided to prepare students to identify and address drug related problems in pediatric patients and to demonstrate competency within those areas. In addition, medical terminology will be learned and applied to the course content.

Introductory Pharmacy Practice Experiences (IPPE) are structured and sequenced rotations to intentionally develop in student pharmacists a clear understanding of what constitutes exemplary pharmacy practice in the U.S. prior to beginning the APPE curriculum. These introductory rotations will involve student pharmacists in common contemporary U.S. practice models, including interprofessional practice involving shared patient care decision making, professional ethics and expected behaviors, and patient care activities. Utilizing ACPE Standards 2025, each IPPE will include the educational outcomes (EO) and the Entrustable Professional Activities (EPA). This course may be conducted in a direct patient care setting or at a site whose activities impact patient care but do not necessarily provide direct patient care.

This course will provide in depth evaluation of methodologies used in pharmacogenomics and the role of genetics in treating diseases. Through readings, lecture, student presentations and discussion, each class will focus on pharmacogenomics applications in various diseases like cardiac, cancer and diabetes.

This course focuses on understanding the process that leads to discovering new drugs. The course covers an understanding of FDA and introduction to various pre-clinical and clinical studies and steps for the FDA approval process. The course will cover an understanding of the drugs that are in different phases of drug development process for many diseases. The course will be an in depth study of the current concepts and literature on specific areas in drug discovery.

"This course focuses on understanding the technologies that are required for the development, production, and manufacture of biological drugs. This course will introduce students to the molecular principles, methods and advanced developmental techniques utilized in the production of therapeutic proteins, hormones, antibodies, and DNA based vaccines. Pharmaceutical delivery methods with an emphasis on controlled release formulations will also be focused in this course. The roles of economic considerations, regulatory issues and the approval of biopharmaceuticals will also be incorporated throughout the course as applicable."

The Student Pharmacist Enrichment Program (SPEP) provides the student pharmacist with an opportunity to expand their perspective in awareness of self and others, innovation, professionalism, and service. Students are encouraged to select personal development activities based on self-assessment of the seven co-curricular elements.

The Student Pharmacist Enrichment Program (SPEP) provides the student pharmacist with an opportunity to expand their perspective in awareness of self and others, innovation, professionalism, and service. Students will identify a personal plan to meet the expectations of the SPEP program based on self-assessment.

The Student Pharmacist Enrichment Program (SPEP) provides the student pharmacist with an opportunity to expand their perspective in awareness of self and others, innovation, professionalism, and service. Students will document self-selected activities in the seven co- curricular elements, accounting for personal plan and expectations of the SPEP program.

The Student Pharmacist Enrichment Program (SPEP) provides the student pharmacist with an opportunity to expand their perspective in awareness of self and others, innovation, professionalism, and service. Students will reflect upon their growth within the seven co- curricular elements after four years within SPEP.

The Pharmacy Board Review course prepares students to take the North American Pharmacist Licensure Examination® (NAPLEX) following graduation through structured facilitation of the completion of online content, textbook, practice questions, and assigned exams that mirror the NAPLEX blueprint and reflect the scope and complexity of the NAPLEX. Co-Req: APPE

Pharmacy graduates are burdened with high student loan debt and may have limited financial literacy. This course aims to provide students with the tools and resources to promote financial self-education, manage debt, save for retirement, and protect against risk. This course will provide the young professional an understanding of personal finance, including topics such as: income taxes, insurance, retirement, investing, estate planning, and student loans.

This course will introduce students to the application of foundational knowledge and essential skills for pharmacy practice and patient care through active learning experiences related to course content delivered simultaneously in other Spring P1 courses. This includes effective communication, verbally and in writing, to both patients and health care practitioners, the use of the pharmacists’ patient care process (PPCP) for self-care conditions, and the application of basic assessment techniques and skills necessary for triage and referral. This course will also provide an introduction to the role of home diagnostic, monitoring and drug delivery devices in the diagnosis, staging, monitoring and treatment of various disease states. Co-Req: PHRM 526

This course will guide students in increasing their self-awareness to influence their personal well-being. Students will evaluate and apply mindfulness approaches and techniques that reduce stress and improve well-being and resiliency. Class discussions will include approaches to improved wellness including but not limited to self-compassion and acceptance and commitment theory. Students will explore tools to support and improve their mindfulness practice. Mindfulness, in-class activities and/or reflection will be engaged in every class.

This course consists of one on one work between a JCP student and faculty member. The faculty member and student mutually develop the goals, objectives and assessments for the completion of the course. Depending upon the workload agreed to, credits may range from 1-3 per semester.

This online course provides a comprehensive overview of pharmacy law, with a special focus on the laws and regulations affecting the day-to-day practice of pharmacy. This course will not only allow the learner to understand the interrelationship of federal and state laws and regulations affecting the practice of pharmacy, but also permit the learner to apply this knowledge in being able to research legal issues as they occur in daily practice. The course will also facilitate the development and application of problem-solving skills based on scenario-based pharmacy management issues presented during class. This course will cover in depth the 2 main laws and related regulations affecting the practice of pharmacy, namely the Food Drug and Cosmetic Act and the Controlled Substance Act. The course will also provide a solid understanding of the Pennsylvania Pharmacy Act and Pharmacy regulations (Title 49, Chapter 27; Title 28, Chapter 25). The course will also cover relevant aspects of Omnibus Budget and Reconciliation Act (OBRA 90), Health Insurance Portability & Accountability Act (HIPAA), and malpractice liability. Finally, the course will emphasize an understanding of the MPJE® competency statements and their respective role as the framework for the MPJE® examination.

Advanced Pharmacy Practice Experiences (APPE) are the final step of learning in the Doctor of Pharmacy curriculum. APPEs allow a Student pharmacist to develop the foundational abilities to be practice-ready upon completion of the fourth professional year of the Doctor of Pharmacy curriculum. Utilizing ACPE Standards 2025, each APPE will include the educational outcomes (EO) and the Entrustable Professional Activities (EPA). This course is conducted in a community setting. All courses designated in the Doctor of Pharmacy curriculum are considered pre-requisite for this course.

Advanced Pharmacy Practice Experiences (APPE) are the final step of learning in the Doctor of Pharmacy curriculum. APPEs allow a Student pharmacist to develop the foundational abilities to be practice-ready upon completion of the fourth professional year of the Doctor of Pharmacy curriculum. Utilizing ACPE Standards 2025, each APPE will include the educational outcomes (EO) and the Entrustable Professional Activities (EPA). This course is conducted in a hospital setting. All courses designated in the Doctor of Pharmacy curriculum are considered pre-requisite for this course.

Advanced Pharmacy Practice Experiences (APPE) are the final step of learning in the Doctor of Pharmacy curriculum. APPEs allow a Student pharmacist to develop the foundational abilities to be practice-ready upon completion of the fourth professional year of the Doctor of Pharmacy curriculum. Utilizing ACPE Standards 2025, each APPE will include the educational outcomes (EO) and the Entrustable Professional Activities (EPA). This course is conducted in an ambulatory care setting. All courses designated in the Doctor of Pharmacy curriculum are considered pre-requisite for this course.

Advanced Pharmacy Practice Experiences (APPE) are the final step of learning in the Doctor of Pharmacy curriculum. APPEs allow a Student pharmacist to develop the foundational abilities to be practice-ready upon completion of the fourth professional year of the Doctor of Pharmacy curriculum. Utilizing ACPE Standards 2025, each APPE will include the educational outcomes (EO) and the Entrustable Professional Activities (EPA). This course is conducted in a direct inpatient care setting. All courses designated in the Doctor of Pharmacy curriculum are considered pre-requisite for this course.

Advanced Pharmacy Practice Experiences (APPE) are the final step of learning in the Doctor of Pharmacy curriculum. APPEs allow a Student pharmacist to develop the foundational abilities to be practice-ready upon completion of the fourth professional year of the Doctor of Pharmacy curriculum. Utilizing ACPE Standards 2025, each APPE will include the educational outcomes (EO) and the Entrustable Professional Activities (EPA). This course is conducted in a direct patient care setting

Advanced Pharmacy Practice Experiences (APPE) are the final step of learning in the Doctor of Pharmacy curriculum. APPEs allow a Student pharmacist to develop the foundational abilities to be practice-ready upon completion of the fourth professional year of the Doctor of Pharmacy curriculum. Utilizing ACPE Standards 2025, each APPE will include the educational outcomes (EO) and the Entrustable Professional Activities (EPA). This course may be conducted in a direct patient care setting or at a site whose activities impact patient care but do not necessarily provide direct patient care. All courses designated in the Doctor of Pharmacy curriculum are considered pre-requisite for this course.

Advanced Pharmacy Practice Experiences (APPE) are the final step of learning in the Doctor of Pharmacy curriculum. APPEs allow a Student pharmacist to develop the foundational abilities to be practice-ready upon completion of the fourth professional year of the Doctor of Pharmacy curriculum. Utilizing ACPE Standards 2025, each APPE will include the educational outcomes (EO) and the Entrustable Professional Activities (EPA). This course may be conducted in a direct patient care setting or at a site whose activities impact patient care but do not necessarily provide direct patient care. All courses designated in the Doctor of Pharmacy curriculum are considered pre-requisite for this course.